These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 7001229)
41. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Marliss EB; Murray FT; Stokes EF; Zinman B; Nakhooda AF; Denoga A; Leibel BS; Albisser AM Diabetes; 1977 Jul; 26(7):663-72. PubMed ID: 873073 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Kitabchi AE; Fisher JN; Burghen GA; Gaylord MS; Blank NM Diabetes Care; 1979; 2(5):421-4. PubMed ID: 510142 [TBL] [Abstract][Full Text] [Related]
43. Quality control of intensified insulin therapy: HbA1 versus blood glucose. Bischof F; Meyerhoff C; Pfeiffer EF Horm Metab Res; 1994 Dec; 26(12):574-8. PubMed ID: 7705761 [TBL] [Abstract][Full Text] [Related]
44. Metabolic response of normal man and insulin-infused diabetics to postprandial exercise. Nelson JD; Poussier P; Marliss EB; Albisser AM; Zinman B Am J Physiol; 1982 May; 242(5):E309-16. PubMed ID: 7044140 [TBL] [Abstract][Full Text] [Related]
45. Long-term continuous intraperitoneal insulin treatment in brittle diabetes. Pozza G; Spotti D; Micossi P; Cristallo M; Melandri M; Piatti PM; Monti LD; Pontiroli AE Br Med J (Clin Res Ed); 1983 Jan; 286(6361):255-6. PubMed ID: 6402060 [TBL] [Abstract][Full Text] [Related]
47. Roles of site and timing of the morning insulin injection in type 1 diabetes. Witt MF; White NH; Santiago JV J Pediatr; 1983 Oct; 103(4):528-33. PubMed ID: 6352884 [TBL] [Abstract][Full Text] [Related]
49. [Treatment of insulin-dependent diabetes by continuous subcutaneous infusion of insulin (author's transl)]. Buysschaert M; Lejeune M; Lambert AE Ann Endocrinol (Paris); 1981; 42(3):293-4. PubMed ID: 7316465 [TBL] [Abstract][Full Text] [Related]
50. Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. McDonald JW; Dupre J; Rodger NW; Champion MC; Webb CD; Ali M Thromb Res; 1982 Dec; 28(6):705-12. PubMed ID: 6762683 [TBL] [Abstract][Full Text] [Related]
51. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Dimitriadis GD; Gerich JE Diabetes Care; 1983; 6(4):374-7. PubMed ID: 6352210 [TBL] [Abstract][Full Text] [Related]
52. A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements. Phillips M; Simpson RW; Holman RR; Turner RC Q J Med; 1979 Jul; 48(191):493-506. PubMed ID: 396545 [No Abstract] [Full Text] [Related]
54. Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients. Bruns W; Bombor H; Jutzi E; Ratzmann KP; Schulz B; Abel P; Fischer U Diabetes Care; 1983; 6(2):112-7. PubMed ID: 6343014 [TBL] [Abstract][Full Text] [Related]
55. [Clinical application and significance of drug delivery systems. Insulin injection therapy of diabetes]. Iwaoka H; Tsuchida H; Makino H; Yoshida S Nihon Rinsho; 1989 Jun; 47(6):1329-34. PubMed ID: 2671444 [No Abstract] [Full Text] [Related]